Results 221 to 230 of about 58,033 (340)
Medical physicists should not encourage or participate in off‐label, non‐FDA‐approved uses of intravascular brachytherapy devices [PDF]
, 2002 Shirish Jani +2 more
openalex +1 more source
Arthritis Care &Research, Accepted Article.Objectives Australian evidence on lived and care experiences of chronic musculoskeletal shoulder pain (CMSP), irrespective of disorder classification or disease, is limited. However, such evidence is important for person‐centred care and informing local service pathways and care guidelines or standards.
Sonia Ranelli +8 more
wiley +1 more source
Integrating medical physics into an EMR-based radiology feedback system for quality improvement. [PDF]
J Appl Clin Med PhysRuss MK +5 more
europepmc +1 more source
All medical physicists entering the field should have a specific course on research and practice ethics in their educational background [PDF]
, 2003 David Switzer +2 more
openalex +1 more source
Hydroxychloroquine Associated with Lower Glomerular Filtration Rate Decline in Lupus Nephritis
Arthritis Care &Research, Accepted Article.Background Hydroxychloroquine (HCQ) protects kidney function in lupus nephritis (LN) by preventing flares, yet some cohort studies show no significant benefit in kidney function with HCQ. Clarifying these conflicting findings by showing early and long‐term benefits of HCQ on kidney function preservation is critical. Therefore, we analyzed data from our
Shivani Garg +9 more
wiley +1 more source
Arthritis Care &Research, Accepted Article.Objective This study examined the global and regional temporal changes in cross‐country inequalities of site‐specific osteoarthritis (OA) burden from 1990 to 2021. Methods Age‐standardized years lived with disability rate for site‐specific OA across 204 countries/territories were obtained from the Global Burden of Diseases Study (GBD) 2021.
Haowei Chen +14 more
wiley +1 more source
Arthritis Care &Research, Accepted Article.Background While treat‐to‐target urate‐lowering therapy (ULT) is endorsed as best practice in gout management, limited data exist on its impact on health‐related quality of life (HRQoL). We assessed the impact of treat‐to‐target ULT on HRQoL among participants receiving protocolized gout care, identifying factors associated with HRQoL and HRQoL change.
Austin Barry +16 more
wiley +1 more source
A case study on SSD to SAD linear acceleartor calibration transition. [PDF]
J Appl Clin Med PhysKoufigar S +4 more
europepmc +1 more source
Arthritis Care &Research, Accepted Article.Objective A leading cause of death among scleroderma (SSc) patients, interstitial lung disease (ILD) remains challenging to prognosticate. The discovery of biomarkers that accurately determine which patients would benefit from close monitoring and aggressive therapy would be an essential clinical tool.
Cristina M Padilla +13 more
wiley +1 more source
AAPM Medical Physics Practice Guideline MPPG 17.a: Quality management for mammography review workstation displays. [PDF]
J Appl Clin Med PhysMilman R +12 more
europepmc +1 more source